For years, healthcare in India has existed in fragments, a neighbourhood chemist for medicines, a diagnostic lab across town, a doctor’s visit squeezed into an already busy day. Access has often depended on geography, awareness, and time, making even routine health decisions feel like effort.
Digital platforms promised to simplify that. And they did to an extent. Medicines could be ordered in minutes, tests booked from home, consultations moved online. But as adoption grew, so did a more fundamental expectation. Convenience was no longer enough. When it comes to health, users aren’t just looking for speed, they’re looking for certainty, credibility, and a system they can rely on repeatedly.
This shift is quietly redefining what digital healthcare brands need to stand for. It’s no longer about enabling a single transaction, but about showing up consistently across a user’s health journey before, during, and beyond moments of illness.
Healthcare in India has always been personal but not always accessible. In a country where convenience often competes with credibility, platforms have had to evolve from being mere service providers to becoming trusted health partners.
That’s exactly the shift PharmEasy is leaning into. What started as a medicine delivery platform is now positioning itself as a full-stack healthcare ecosystem, one that doesn’t just respond to illness, but actively participates in a user’s long-term health journey.
In a conversation with Brand Beats, Gaurav Verma, Chief Business Officer, breaks down how PharmEasy is moving beyond transactions, why trust can’t be marketed overnight, and what India’s next wave of digital healthcare adoption really looks like.
Building for the Entire Health Journey
PharmEasy’s evolution reflects a broader shift in digital health from reactive services to continuous care.
“PharmEasy has evolved from a medicine delivery partner to a more integrated healthcare platform, focused on supporting users across different stages of their health journey,” Verma explains.
Today, the platform brings together diagnostics, online consultations, at-home services like vaccination and physiotherapy, along with elder care creating what he calls a “seamless healthcare experience under one roof.” This expansion isn’t just about adding services. It’s about increasing relevance in everyday health decisions, not just emergency needs.
“We’re moving from one-time transactions to more continuous, long-term healthcare engagement,” he adds.
Marketing in Healthcare
In most categories, marketing can create perception. In healthcare, it has to reinforce reality. Verma is clear about this distinction. “Trust isn’t built through messaging alone, it comes from consistently delivering a reliable experience,” he says.
This thinking shows up in tangible commitments like service guarantees such as “On-time or Free” diagnostics that go beyond communication and into accountability. At the same time, PharmEasy is doubling down on credibility-led storytelling.
“We’re leaning into doctor-led communication and medically accurate content to make health information more credible,” he notes, adding that regional and vernacular outreach is key to expanding relevance in Tier 2 and Tier 3 markets.
And underpinning it all is a simple but powerful truth “When people order medicines or book a test, they are placing their health in our hands. That responsibility shapes every decision we make.”
Inside the Campaign That Put Young India’s Heart Health in Focus
For its World Health Day initiative, PharmEasy chose to spotlight a growing yet often under-recognised issue of rising heart health risks among younger Indians.
“Heart-related conditions are increasingly being seen among younger Indians, often without clear warning signs. We wanted to make preventive heart checkups essential, enabling early detection and timely intervention,” Verma explains.
This insight became the foundation of a campaign designed to shift behaviour from reactive treatment to preventive care. By offering at-home ECGs, free cardiologist consultations, and bundled checkup packages, the idea was to make that first step towards heart health easier and more accessible.
A key part of bringing this narrative to life was the inclusion of health educator Prashant Desai, a move rooted not just in reach, but in credibility and relatability. “His voice, combined with his personal connection to heart health, helped us make the message more real and more urgent. We wanted to reach younger Indians who don’t typically think about heart health but should,” Verma shares.
View this post on Instagram
The campaign ultimately underscored a critical truth that cardiac issues often develop silently over decades, while simplifying access to diagnostics and expert consultation, turning awareness into action.
What Worked, What Surprised & How Success of a Campaign Is Measured
Like most health conversations today, the campaign found strong traction on digital platforms, especially short-form video. “We saw high organic sharing, which told us the topic was striking a genuine chord, not just driving passive views. And people in their 30s weren’t just watching, they were tagging family members and booking checkups, often for the first time,” Verma says.
The real surprise, however, was who engaged the most. That shift reinforced a key insight: preventive healthcare is no longer an “older demographic” conversation.
But for PharmEasy, the campaign’s success isn’t judged by immediate conversions alone.
Unlike traditional e-commerce, healthcare marketing operates on a longer horizon, where trust, recall, and behaviour change take time to build. The focus, therefore, is on deeper signals like awareness, engagement, organic conversations, and perception of reliability.
“We don’t look at campaigns only through a transactional lens, especially in healthcare, where trust and recall take time to build. Ultimately, success is about building a strong, lasting relationship so that when a healthcare need arises, we are the first choice,” Verma explains.
Revenue Realities and the Brand vs Performance Balance
While e-pharmacy continues to drive the largest share of revenue, diagnostics is rapidly emerging as a strong growth engine for PharmEasy.
“Diagnostics benefits from the trust users place in us for high-stakes, in-home services. What excites us is the direction we’re heading, toward recurring healthcare services like consultations, nursing, physiotherapy, and elder care” Verma notes, pointing to how user confidence is directly shaping category growth. But for the company, the bigger opportunity lies beyond its current mix. The ambition is clear: to evolve into a platform users rely on across their entire health lifecycle not just for one-off needs.
At the same time, building that future requires a careful balance in how the brand grows today. For many digital-first companies, performance marketing is the primary growth engine but in healthcare, that’s only part of the story.
“Performance marketing has become sharper, but it can’t build the kind of trust a healthcare brand ultimately needs,” Verma says. That’s where brand-building steps in not as a replacement, but as a foundation.
“You can acquire a user through a discount but you earn loyalty through consistent experience and credibility,” he explains. Instead of treating them as competing levers, PharmEasy is investing in both with clearly defined roles ensuring that short-term acquisition and long-term trust build in tandem.
Breaking Misconceptions Around Digital Healthcare
Despite rapid adoption, digital healthcare still carries its share of myths. “The biggest misconception is that it’s just about convenience, a faster way to get medicines delivered,” Verma points out.
In reality, the ecosystem has expanded far beyond that from AI-powered diagnostics to at-home medical services. Another persistent concern is authenticity.
“People still worry about whether medicines sourced online are genuine and that’s something the industry needs to address collectively,” he says. For PharmEasy, that means treating operational decisions, like sourcing and partnerships as brand commitments.
Decoding India’s Healthcare Divide
One of the most defining insights for PharmEasy lies in how differently India is adopting digital healthcare and why a one-size-fits-all approach simply doesn’t work.
“In metros, adoption is driven by convenience; it’s faster and simpler than existing options. “In Tier 2 and Tier 3 markets, we’re often enabling access where none existed before.” Verma explains.
In urban markets, users are choosing digital healthcare because it saves time, reduces friction, and fits seamlessly into their already busy lives. But step outside metros, and the role of these platforms changes entirely.
Here, the value isn’t just convenience, it’s availability. From reliable medicine supply to quality diagnostics and consultations, digital healthcare is solving for gaps that traditional infrastructure hasn’t fully addressed. This contrast between convenience-led adoption and access-led adoption is shaping how PharmEasy is thinking about scale, expansion, and long-term impact.
At the same time, operating in a fast-growing but crowded category brings its own challenges especially when it comes to differentiation. “Long-term differentiation in healthcare can’t be built on price, it has to come from reliability and consistency,” Verma states.
In a space where trust directly impacts decision-making, competing on discounts alone is not only unsustainable but also insufficient. PharmEasy’s approach is to strengthen its edge through experience and technology whether that’s simplifying complex health data through AI-powered report interpretation or enabling users to track their health metrics over time.
“As the category matures, users will prioritise trust, convenience, and consistency over short-term discounts,” he concludes. The play, then, is not about being the cheapest option in the market, but about being the most dependable one across both Indias.
